Assessing medication adherence in the elderly: Which tools to use in clinical practice?

Drugs and Aging

Volumn 22, Issue 3, 2005, Pages 231-255

  MacLaughlin, Eric J ^a   Raehl, Cynthia L ^a   Treadway, Angela K ^a   Sterling, Teresa L ^a   Zoller, Dennis P ^a   Bond, Chester A ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIASTHMATIC AGENT; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIGLAUCOMA AGENT; ANTIHYPERTENSIVE AGENT; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; ANTIRHEUMATIC AGENT; ANTITHROMBOCYTIC AGENT; ANXIOLYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CALCITONIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HERBACEOUS AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INFLUENZA VACCINE; NEUROLEPTIC AGENT; NON PRESCRIPTION DRUG; PARACETAMOL; PNEUMOCOCCUS VACCINE; UNINDEXED DRUG;

AUTOMATION; BREAST CANCER; CARDIOVASCULAR DISEASE; CAREGIVER; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PRACTICE; COGNITIVE DEFECT; COMORBIDITY; DELIRIUM; DEMOGRAPHY; DEVICE; DRUG COST; DRUG DELIVERY SYSTEM; DRUG MONITORING; ELDERLY CARE; FALLING; GLAUCOMA; HEARING IMPAIRMENT; HEART FAILURE; HOSPITALIZATION; HUMAN; INTERVIEW; METERED DOSE INHALER; NURSING HOME; ORTHOSTATIC HYPOTENSION; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHARMACIST; PREDICTION; PRESCRIPTION; PRIORITY JOURNAL; READING; REVIEW; SCREENING; SELF REPORT; VISUAL IMPAIRMENT;

PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL PREPARATIONS; PHARMACISTS; PROFESSIONAL ROLE; REMINDER SYSTEMS; SELF ADMINISTRATION; TREATMENT REFUSAL;

EID: 17244364722     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-200522030-00005     Document Type: Review

References (127)

1. Haynes RB, McDonald H, Garg AX, et al. Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst Rev 2002; (2): CD00001
2. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions: scientific review. JAMA 2002; 288: 2868-79
3. Roter DL, Hall JA, Merisca R, et al. Effectiveness of interventions to improve patient compliance: a meta analysis. Med Care 1998; 36: 1138-61
4. van Eijken M, Tsang S, Wensing M, et al. Interventions to improve medication compliance in older patients living in the community: a systematic review of the literature. Drugs Aging 2003; 20: 229-40
5. Urquhart J, Chevalley C. Impact of unrecognized dosing errors on the cost and effectiveness of pharmaceuticals. Drug Inf J 1988; 22: 363-78
6. Peterson AM, Takiya L, Finley R. Meta-analysis of trials of interventions to improve medication adherence. Am J Health Syst Pharm 2003; 60: 657-65
7. Merriam-Webster. Merriam-Webster online dictionary [online]. Available from URL: http://www.m-w.com/cgi-bin/dictionary?.book=Dictionary&va= compliance [Accessed 2004 Mar 30]
8. Urquhart J. Role of patient compliance in clinical pharmacokinetics: a review of recent research. Clin Pharmacokinet 1994; 27: 202-15
9. Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841-5
10. Chan M, Nicklason F, Vial JH. Adverse drug events as a cause of hospital admission in the elderly. Intern Med J 2001; 31: 199-205
11. Morrow D, Leirer V, Sheikh J. Adherence and medication instructions: review and recommendations. J Am Geriatr Soc 1988; 36: 1147-60
12. Gray SL, Mahoney JE, Blough DK. Medication adherence in elderly patients receiving home health services following hospital discharge. Ann Pharmacother 2001; 35: 539-45
13. Cramer JA. Microelectronic systems for monitoring and enhancing patient compliance with medication regimens. Drugs 1995; 49: 321-7
14. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998; 20: 764-71
15. Cooper JK, Love DW, Raffoul PR. Intentional prescription nonadherence (noncompliance) by the elderly. J Am Geriatr Soc 1982; 30: 329-33
16. Coons SJ, Sheahan SL, Martin SS, et al. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994; 16: 110-7
17. Monane M, Bohn RL, Gurwitz JH, et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health 1996; 86: 1805-8
18. Billups SJ, Malone DC, Carter BL. The relationship between drug therapy noncompliance and patient characteristics, health-related quality of life, and health care costs. Pharmacotherapy 2000; 20: 941-9
19. Park DC, Morrell RW, Frieske D, et al. Medication adherence behaviors in older adults: effects of external cognitive supports. Psychol Aging 1992; 7: 252-6
20. Andrus MR, Roth MT. Health literacy: a review. Pharmacotherapy 2002; 22: 282-302
21. Baker DW, Gazmararian JA, Sudano J, et al. The association between age and health literacy among elderly persons. J Gerontol B Psychol Sci Soc Sci 2000; 55: S368-74
22. Gazmararian JA, Baker DW, Williams MV, et al. Health literacy among Medicare enrollees in a managed care organization. JAMA 1999; 281: 545-51
23. Scott TL, Gazmararian JA, Williams MV, et al. Health literacy and preventive health care use among Medicare enrollees in a managed care organization. Med Care 2002; 40: 395-404
24. Health literacy: report of the Council on Scientific Affairs. Ad Hoc Committee on Health Literacy for the Council on Scientific Affairs, American Medical Association. JAMA 1999; 281: 552-7
25. Baker DW, Williams MV, Parker RM, et al. Development of a brief test to measure functional health literacy. Patient Educ Couns 1999; 38: 33-42
26. Ruscin JM, Semla TP. Assessment of medication management skills in older outpatients. Ann Pharmacother 1996; 30: 1083-8
27. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000; 160: 2101-7
28. Raehl CL, Bond CA, Woods T, et al. Individualized drug use assessment in the elderly. Pharmacotherapy 2002; 22: 1239-48
29. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001; 23: 1296-310
30. Christensen DB, Williams B, Goldberg HI, et al. Assessing compliance to antihypertensive medications using computer-based pharmacy records. Med Care 1997; 35: 1164-70
31. Eisen SA, Miller DK, Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881-4
32. Cramer J, Vachon L, Desforges C, et al. Dose frequency and dose interval compliance with multiple antiepileptic medications during a controlled clinical trial. Epilepsia 1995; 36: 1111-7
33. Cramer JA, Mattson RH, Prevey ML, et al. How often is medication taken as prescribed? A novel assessment technique. JAMA 1989; 261: 3273-7
34. Taggart AJ, Johnston GD, McDevitt DG. Does the frequency of daily dosage influence compliance with digoxin therapy? Br J Clin Pharmacol 1981; 11: 31-4
35. Kruse W, Eggert-Kruse W, Rampmaier J, et al. Dosage frequency and drug-compliance behaviour: a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol 1991; 41: 589-92
36. Tinkelman DG, Vanderpool GE, Carroll MS, et al. Compliance differences following administration of theophylline at six- and twelve-hour intervals. Ann Allergy 1980; 44: 283-6
37. Pullar T, Birtwell AJ, Wiles PG, et al. Use of a pharmacologic indicator to compare compliance with tablets prescribed to be taken once, twice, or three times daily. Clin Pharmacol Ther 1988; 44: 540-5
38. Pushpangadan M, Feely M. Once a day is best: evidence or assumption? The relationship between compliance and dosage frequency in older people. Drugs Aging 1998; 13: 223-7
39. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther 1984; 6: 593-9
40. Boissel JP, Nony P. Using pharmacokinetic-pharmacodynamic relationships to predict the effect of poor compliance. Clin Pharmacokinet 2002; 41: 1-6
41. Rudd P, Lenert L. Pharmacokinetics as an aid to optimising compliance with medications. Clin Pharmacokinet 1995; 28: 1-6
42. Burris JF, Papademetriou V, Wallin JD, et al. Therapeutic adherence in the elderly: transdermal clonidine compared to oral verapamil for hypertension. Am J Med 1991; 91: 22S-8S
43. de Klerk E. Patient compliance with enteric-coated weekly fluoxetine during continuation treatment of major depressive disorder. J Clin Psychiatry 2001; 62: 43-7
44. Stewart RB. Noncompliance in the elderly: is there a cure? Drugs Aging 1991; 1: 163-7
45. Sharkness CM, Snow DA. The patient's view of hypertension and compliance. Am J Prev Med 1992; 8: 141-6
46. Lakshman M, Fernando M, Kazarian SS. Patient education in the drug treatment of psychiatric disorders. CNS Drugs 1995; 3: 291-304
47. Stewart RB, Caranasos GJ. Medication compliance in the elderly. Med Clin North Am 1989; 73: 1551-63
48. Lin IF, Spiga R, Fortsch W. Insight and adherence to medication in chronic schizophrenics. J Clin Psychiatry 1979; 40: 430-2
49. Jackevicius CA, Mamdani M, Tu JV. Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002; 288: 462-7
50. Meredith PA. Therapeutic implications of drug 'holidays'. Eur Heart J 1996; 17 Suppl. A: 21-4
51. Pullar T. Compliance with drug therapy. Br J Clin Pharmacol 1991; 32: 535-9
52. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med 1990; 150: 1509-10
53. Feinstein AR. On white-coat effects and the electronic monitoring of compliance. Arch Intern Med 1990; 150: 1377-8
54. Garfield FB, Caro JJ. Achieving patient buy-in and long term compliance with antihypertensive treatment. Dis Manage Health Outcomes 2000; 7: 13-20
55. Willey C, Redding C, Stafford J, et al. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther 2000; 22: 858-71
56. Edelberg HK, Shallenberger E, Wei JY. Medication management capacity in highly functioning community-living older adults: detection of early deficits. Am Geriatr Soc 1999; 47: 592-6
57. Pullar T, Kumar S, Tindall H, et al. Time to stop counting the tablets? Clin Pharmacol Ther 1989; 46: 163-8
58. Rudd P, Byyny RL, Zachary V, et al. The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther 1989; 46: 169-76
59. Paes AH, Bakker A, Soe-Agnie CJ. Measurement of patient compliance. Pharm World Sci 1998; 20: 73-7
60. Mojtabai R, Olfson M. Medication costs, adherence, and health outcomes among medicare beneficiaries. Health Affairs 2003; 22: 220-9
61. Paris W, Dunham S, Sebastian A, et al. Medication nonadherence and its relation to financial restriction. J Transpl Coord 1999; 9: 149-52
62. Schoen MD, DiDomenico RJ, Connor SE, et al. Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease. Pharmacotherapy 2001; 21: 1455-63
63. Secnik K, Pathak DS, Cohen JM. Postcard and telephone reminders for unclaimed prescriptions: a comparative evaluation using survival analysis. J Am Pharm Assoc (Wash) 2000; 40: 243-51
64. Meyer ME, Schuna AA. Assessment of geriatric patients' functional ability to take medication. DICP 1989; 23: 171-4
65. Fitten LJ, Coleman L, Siembieda DW, et al. Assessment of capacity to comply with medication regimens in older patients. J Am Geriatr Soc 1995; 43: 361-7
66. Edelberg HK, Shallenberger E, Wei JY. One-year follow-up of medication management capacity in highly functioning older adults. J Gerontol A Biol Sci Med Sci 2000; 55: M550-3
67. Hurd PD, Blevins J. Aging and the color of pills [letter]. N Engl J Med 1984; 310: 202
68. Hurd PD, Butkovich SL. Compliance problems and the older patient: assessing functional limitations. Drug Intell Clin Pharm 1986; 20: 228-31
69. Keram S, Williams ME. Quantifying the ease or difficulty older persons experience in opening medication containers. J Am Geriatr Soc 1988; 36: 198-201
70. Morrell RW, Park DC, Poon LW. Quality of instructions on prescription drug labels: effects on memory and comprehension in young and old adults. Gerontologist 1989; 29: 345-54
71. Murray MD, Daraell J, Weinberger M, et al. Factors contributing to medication noncompliance in elderly public housing tenants. Drug Intell Clin Pharm 1986; 20: 146-52
72. Morrell RW, Park DC, Poon LW. Effects of labeling techniques on memory and comprehension of prescription information in young and old adults. J Gerontol 1990; 45: P166-72
73. Hanchak NA, Patel MB, Berlin JA, et al. Patient misunderstanding of dosing instructions. J Gen Intern Med 1996; 11: 325-8
74. Isaac LM, Tamblyn RM. Compliance and cognitive function: a methodological approach to measuring unintentional errors in medication compliance in the elderly. McGill-Calgary Drug Research Team. Gerontologist 1993; 33: 772-81
75. Turner J, Wright E, Mendella L, et al. Predictors of patient adherence to long-term home nebulizer therapy for COPD. The IPPB Study Group. Intermittent Positive Pressure Breathing. Chest 1995; 108: 394-400
76. Gray SL, Williams DM, Pulliam CC, et al. Characteristics predicting incorrect metered-dose inhaler technique in older subjects. Arch Intern Med 1996; 156: 984-8
77. Partridge AH, Wang PS, Winer EP, et al. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 2003; 21: 602-6
78. Roe CM, Motheral BR, Teitelbaum F, et al. Compliance with and dosing of angiotensin-converting-enzyme inhibitors before and after hospitalization. Am J Health Syst Pharm 2000; 57: 139-45
79. Camus V, Kraehenbuhl H, Preisig M, et al. Geriatric depression and vascular diseases: what are the links? J Affect Disord 2004; 81 (1): 1-16.
80. Wang PS, Bohn RL, Knight E, et al. Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med 2002; 17: 504-11
81. Ziegelstein RC, Bush DE, Fauerbach JA. Depression, adherence behavior, and coronary disease outcomes. Arch Intern Med 1998; 158: 808-9
82. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000; 160: 3278-85
83. Gurwitz JH, Yeomans SM, Glynn RJ, et al. Patient noncompliance in the managed care setting: the case of medical therapy for glaucoma. Med Care 1998; 36: 357-69
84. Rivers PH. Compliance aids: do they work? Drugs Aging 1992; 2: 103-11
85. Winfield AJ, Jessiman D, Williams A, et al. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990; 74: 477-80
86. Averns H, Hall J, Webley M. Role of opticare eye drop delivery system in patients with rheumatoid arthritis. J Rheumatol 1999; 26: 2615-8
87. Easidrop. Easidrop: the 'award winning' eyedrop guide [online]. Available from URL: http://www.easidrop.com [Accessed 2003 Aug 22]
88. American Family Medical. Owen Mumford Autodrop® eyedropper aid [online]. Available from URL: http://store.yahoo.com/americanfamily/owauteyaid. html [Accessed 2003 Aug 22]
89. The Medical Supply Company Inc. Autodrop eyedropper aid [online]. Available from URL: http://www.medsupplyco.com/OWNOP6000.shtml [Accessed 2003 Aug 22]
90. Owen Mumford. Autodrop [online]. Available from URL: http://www. owenmumford.corn/brochure-ec.htm#autodrop [Accessed 2003 Aug 22]
91. Westons Internet. Opticare eye drop dispensers [online]. Available from URL: http://www.westons.com/prodhh33.htm [Accessed 2003 Aug 22 ]
92. W+W Medsystems. Opticare & opticare arthro [online]. Available from URL: http://www.wwmed.co.uk/Cameron%20 Graham%20Associates/opticare/index.htm [Accessed 2003 Aug 22]
93. RNIB. Online shop: eye drop dispenser, opticare [online]. Available from URL: http://onlineshop.rnib.org.uk/display_product.asp?.prodid=938&status=2 [Accessed 2003 Aug 22]
94. Girvin B, Johnston GD. The implications of noncompliance with antihypertensive medication. Drugs 1996; 52: 186-95
95. Struthers AD, MacFadyen R, Fraser C, et al. Nonadherence with angiotensin-converting enzyme inhibitor therapy: a comparison of different ways of measuring it in patients with chronic heart failure. J Am Coll Cardiol 1999; 34: 2072-7
96. BirdSong Medical Devices, Inc. The Doser [online]. Available from URL: http://birdsongmedical.net [Accessed 2003 Sep 15]
97. E-Pill. CompuMed - E-pill medication reminders [online]. Available from URL: http://www.epill.com/compumed.html [Accessed 2005 Feb 14]
98. E-Pill. Beep n' tell - E-Pill medication reminders [online]. Available from URL: http://www.epill.com [Accessed 2003 Aug 22]
99. E-Pill. HealthWatch & Windows PC software - E-Pill medication reminders [online]. Available from URL: http://www.epill.com [Accessed 2005 Feb 14]
100. ResponseLink Inc. ResponseLink [online]. Available from URL: http://www.responselink.com [Accessed 2003 Aug 22]
101. Lifeline Systems Inc. Lifeline [online]. Available from URL: http://www.lifelinesys.com [Accessed 2003 Aug 22]
102. E-Pill. Kind Remind - E-Pill medication reminders [online]. Available from URL: http://www.epill.com [Accessed 2003 Aug 22]
103. PTH Corporation. PTH LogPad [online]. Available from URL: http://www.phtcorp.com [Accessed 2003 Aug 22]
104. Drugstore.com. MEDGlider pill case [online]. Available from URL: http://www.drugstore.com [Accessed 2005 Feb 14]
105. Information Mediary Corporation. Med-ic digital package [online]. Available from URL: http://www.informationmediary.com/med-ic.htm [Accessed 2003 Aug 22]
106. E-Pill. Med-Time - E-Pill medication reminders [online]. Available from URL: http://www.epill.com [Accessed 2003 Aug 22]
107. Center for Internal Change. WatchMinder 01110 [online]. Available from URL: http://www.internalchange.com/watchminder/itmidxl.htm [Accessed 2005 Feb 14]
108. Guthrie RM. The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction program. Clin Ther 2001; 23: 970-80
109. Simkins CV, Wenzloff NJ. Evaluation of a computerized reminder system in the enhancement of patient medication refill compliance. Drug Intell Clin Pharm 1986; 20: 799-802
110. Tavitian SM, Kidder PA, Shane R. Contacting patients with unclaimed prescriptions: the pharmacist's impact on drug therapy concordance. Hosp Pharm 2001; 36: 1060-5
111. Ascione FJ, Brown GH, Kirking DM. Evaluation of a medication refill reminder system for a community pharmacy. Patient Educ Couns 1985; 7: 157-65
112. Bishop SK, Winckler SC. Implementing HIPAA privacy regulations in pharmacy practice. J Am Pharm Assoc (Wash) 2002; 42: 836-44
113. AARDEX Ltd. MEMS IV monitors [online]. Available from URL: http://www.aardexus.com/mems4mon2.htm [Accessed 2004 Mar 31]
114. AARDEX Ltd. Advanced anlytical research on drug experience [online]. Available from URL: http://www.aardexus.com/default.htm [Accessed 2003 Aug 30]
115. Choo PW, Rand CS, Inui TS, et al. Validation of patient reports, automated pharmacy records, and pill counts with electronic monitoring of adherence to antihypertensive therapy. Med Care 1999; 37: 846-57
116. Averbuch M, Weintraub M, Pollock DJ. Compliance assessment in clinical trials: the MEMS device. J Clin Res Pharmacoepidemiol 1990; 4: 199-204
117. Waterhouse DM, Calzone KA, Mele C, et al. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 1993; 11: 1189-97
118. Burney KD, Krishnan K, Ruffin MT, et al. Adherence to single daily dose of aspirin in a chemoprevention trial: an evaluation of self-report and microelectronic monitoring. Arch Fam Med 1996; 5: 297-300
119. Straka RJ, Fish JT, Benson SR, et al. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy 1997; 17: 126-32
120. Kruse W, Weber E. Dynamics of drug regimen compliance: its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol 1990; 38: 561-5
121. Matsuyama JR, Mason BJ, Jue SG. Pharmacists' interventions using an electronic medication-event monitoring device's adherence data versus pill counts. Ann Pharmacother 1993; 27: 851-5
122. Wendel CS, Mohler MJ, Kroesen K, et al. Barriers to use of electronic adherence monitoring in an HIV clinic. Ann Pharmacother 2001; 35: 1010-5
123. Nides MA, Tashkin DP, Simmons MS, et al. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest 1993; 104: 501-7
124. Julius SM, Sherman JM, Hendeles L. Accuracy of three electronic monitors for metered-dose inhalers. Chest 2002; 121: 871-6
125. Simmons MS, Nides MA, Rand CS, et al. Trends in compliance with bronchodilator inhaler use between follow-up visits in a clinical trial. Chest 1996; 109: 963-8
126. Winland-Brown JE, Valiante J. Effectiveness of different medication management approaches on elders' medication adherence. Outcomes Manag Nurs Pract 2000; 4: 172-6
127. Cherry JC, Moffatt TP, Rodriguez C, et al. Diabetes disease management program for an indigent population empowered by telemedicine technology. Diabetes Technol Ther 2002; 4: 783-91